Finance

Lists
Why is TAK up 2,65%?
Dive Deeper
TAK:NYSE
Takeda Pharmaceutical Co Ltd
19,01 $
+2,65%
(+0,49) 1D
19,01 $
0,00% (0,00)
After hours
Closed: 14 қаз., 16:00:05 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TAK...
Open
18,63 $
High
19,04 $
Low
18,57 $
Mkt. cap
61,83 млрд
Avg. vol.
2,42 млн
Volume
4,68 млн
Dividend
3,32%
Quarterly dividend
0,16 $
Ex-dividend date
2026 ж. 29 қыр.
52-wk high
19,10 $
52-wk low
12,99 $
EPS
-0,33 $
Beta
-0,06
Shares outstanding
3,20 млрд
No. of employees
47 мың
Open
18,63 $
High
19,04 $
Low
18,57 $
Mkt. cap
61,83 млрд
Avg. vol.
2,42 млн
Volume
4,68 млн
Dividend
3,32%
Quarterly dividend
0,16 $
Ex-dividend date
2026 ж. 29 қыр.
52-wk high
19,10 $
52-wk low
12,99 $
EPS
-0,33 $
Beta
-0,06
Shares outstanding
3,20 млрд
No. of employees
47 мың
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
11 сағат бұрын
Trading the Move, Not the Narrative: (TAK) Edition
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees47 мың
Founded1781 ж. 12 мау.
Headquarters-
SectorPharmaceutical industry
Websitetakeda.com
Analyst ratings
Based on 1 analyst giving stock ratings to TAK in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for TAK in the last 3 months
Highest
Current 19,01 $
42,94 $ (+125,86%)
Average
42,94 $ (+125,88%)
Lowest
42,94 $ (+125,86%)
Analyst
Recommendation
Action
Price target
Projected
Date
Koichi Mamegano
Bank of America Securities
Buy
Maintained
6 800,00 JP¥
+35 670,6%
09/14/2026
Michael Nedelcovych
TD Cowen
Buy
Maintained
21,00 $
+10,5%
06/04/2026
Last report
2026 ж. 30 шіл.
Fiscal period
Q1 2026
77,00 JP¥ / -
0,00%miss
Revenue / Est. (JPY)
1,22 трлн / 1,15 трлн
+6,12%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
1,11 трлн
1,19 трлн
1,09 трлн
1,22 трлн
Cost of goods sold
380,06 млрд
401,15 млрд
453,33 млрд
406,68 млрд
Cost of revenue
380,06 млрд
401,15 млрд
453,33 млрд
406,68 млрд
Research and development expenses
161,48 млрд
175,23 млрд
187,96 млрд
167,40 млрд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
253,55 млрд
282,78 млрд
291,96 млрд
286,51 млрд
Operating expense
562,57 млрд
661,30 млрд
519,65 млрд
612,60 млрд
Total operating expenses
942,63 млрд
1,06 трлн
972,98 млрд
1,02 трлн
Operating income
170,17 млрд
129,25 млрд
121,56 млрд
200,62 млрд
Other non operating income
77,96 млрд
-197,22 млрд
181,53 млрд
-28,14 млрд
EBT including unusual items
28,17 млрд
133,86 млрд
-455,02 млрд
162,72 млрд
EBT excluding unusual items
128,86 млрд
114,17 млрд
71,49 млрд
161,92 млрд
Income tax expense
39,90 млрд
30,13 млрд
-86,62 млрд
49,46 млрд
Effective tax rate
141,64%
22,51%
19,04%
30,40%
Other operating expenses
16,12 млрд
67,13 млрд
-64,27 млрд
53,17 млрд
Net income
-11,80 млрд
103,64 млрд
-368,47 млрд
113,20 млрд
Net profit margin
-1,06%
8,70%
-33,66%
9,28%
Earnings per share
-
-
-
-
Interest and investment income
43,92 млрд
181,35 млрд
-
24,61 млрд
Interest expense
-161,10 млрд
-
-239,63 млрд
-35,70 млрд
Net interest expenses
-117,18 млрд
181,35 млрд
-239,63 млрд
-11,09 млрд
Depreciation and amortization charges
-
-
-
-
EBITDA
355,15 млрд
319,89 млрд
192,73 млрд
363,66 млрд
Gain or loss from assets sale
303,00 млн
358,00 млн
1,46 млрд
-6,00 млрд
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары